| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 28.374 | 52.902 | 64.068 | 73.896 | 80.757 | 134.572 | 112.165 | 154.595 | 175.340 |
| Total Income - EUR | - | 28.375 | 52.903 | 64.069 | 73.898 | 82.828 | 134.573 | 112.172 | 154.622 | 175.599 |
| Total Expenses - EUR | - | 12.239 | 30.635 | 35.422 | 30.244 | 24.787 | 24.151 | 25.709 | 27.357 | 25.334 |
| Gross Profit/Loss - EUR | - | 16.136 | 22.268 | 28.648 | 43.654 | 58.040 | 110.421 | 86.463 | 127.265 | 150.265 |
| Net Profit/Loss - EUR | - | 15.852 | 21.516 | 28.007 | 42.915 | 57.286 | 109.257 | 85.341 | 125.719 | 145.003 |
| Employees | - | 4 | 0 | 3 | 3 | 1 | 1 | 2 | 2 | 1 |
Check the financial reports for the company - Ogepet Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 112 | 13.254 | 10.005 | 4.884 | 440 | 102 | 102 | 973 | 1.493 |
| Current Assets | - | 22.198 | 13.086 | 38.850 | 60.321 | 59.067 | 112.664 | 91.769 | 131.075 | 167.917 |
| Inventories | - | 29 | 56 | 55 | 208 | 204 | 644 | 1.739 | 1.841 | 3.087 |
| Receivables | - | 1.923 | 4.464 | 6.267 | 8.253 | 8.588 | 11.712 | 69.014 | 96.036 | 108.792 |
| Cash | - | 20.246 | 8.565 | 32.528 | 51.860 | 50.275 | 100.308 | 21.015 | 33.198 | 56.038 |
| Shareholders Funds | - | 15.896 | 21.820 | 44.902 | 62.547 | 57.327 | 110.626 | 85.427 | 125.759 | 145.043 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 6.414 | 4.520 | 3.952 | 2.658 | 2.180 | 2.140 | 6.444 | 6.288 | 24.367 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Ogepet Med Srl